Investment
Features
FeesSafety
Academy
More
Pluang+

Compare T-Rex 2X Long MSTR Daily Target ETF (MSTU) vs Royalty Pharma plc Class A Ordinary Shares (RPRX) Price & Performance

T-Rex 2X Long MSTR Daily Target ETFTrade
Royalty Pharma plc Class A Ordinary SharesTrade

Price performance (Past 24H)

Key statistics

T-Rex 2X Long MSTR Daily Target ETF vs Royalty Pharma plc Class A Ordinary Shares — how do they compare? T-Rex 2X Long MSTR Daily Target ETF trades at $39.7 (market cap $809.00M), while Royalty Pharma plc Class A Ordinary Shares trades at $56.93 (market cap $25.27B). The key difference: Royalty Pharma plc Class A Ordinary Shares is far larger — about 31.2× T-Rex 2X Long MSTR Daily Target ETF's market cap, and Royalty Pharma plc Class A Ordinary Shares pays a 1.66% dividend while T-Rex 2X Long MSTR Daily Target ETF pays none. Which is the better fit depends on your goals — on Pluang, investors hold T-Rex 2X Long MSTR Daily Target ETF for 18 Days and Royalty Pharma plc Class A Ordinary Shares for 1 Days on average.

MSTURPRX
Market Cap
$809.00M$25.27B
Volume
4,577,4653,671,183
Sector
Leveraged / InverseHealth
52-Week High
$451.00$63.96
52-Week Low
$14.60$35.44
Typical Hold Time
18 Days1 Days
Enterprise Value
—$32.50B
Dividend Yield
—1.66%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

T-Rex 2X Long MSTR Daily Target ETF

MSTU trades at $39.70, up 0.63% with bearish technical indicators showing 8 buy vs 13 sell signals. The stock faces resistance at $40-$43 with support at $37-$33. Recent corporate actions include a 10:1 reverse stock split effective August 24, 2026, and a $0.29 dividend declaration for H2-2026. Trading activity remains elevated as investors seek leveraged exposure to the underlying company.

The outlook remains cautious with technical weakness outweighing neutral oscillators. Key risks include the leveraged ETF structure's daily rebalancing effects and dependence on underlying stock volatility. Investment appeal hinges on continued institutional interest in the strategy exposure, though the bearish technical setup suggests near-term pressure.

Royalty Pharma plc Class A Ordinary Shares

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

MSTU
43% Buy57% Sell
Avg holding period · 18 Days
RPRX

No sentiment data available yet.

Top news

Latest headlines on both assets

About T-Rex 2X Long MSTR Daily Target ETF

MSTU is a leveraged ETF that seeks daily investment results corresponding to 200% of the daily performance of the MicroStrategy Incorporated (MSTR) stock. It is designed as a tactical tool for experienced traders to take a bullish (long) position in MSTR, a company known for its significant Bitcoin holdings. Due to the effects of compounding and leverage, the ETF is intended to be held for a single day and is not suitable for long-term investment.

Read more on MSTU →

About Royalty Pharma plc Class A Ordinary Shares

Royalty Pharma acquires interests in royalties from biopharmaceutical products. Its model gives it exposure to medicines developed and sold by other life sciences companies.

Read more on RPRX →